Abstract
Depression and anxiety are some of the most common mental health disorders in the world contributing to significant morbidity and mortality. Past treatments have focused primarily on treating depression and anxiety. However, there is an urgent need to detect chronic stress states and potentially intervene using just-in-time personalized interventions. Modern technology has revolutionized our ability to passively measure various biological and physiological signals. In our daily lives, we generate significant amounts of electronic data from our phones, wearable technology, watches, and even computers and cars. In this analysis, we focus on using wearable data from FitBit to passively predict daily mood states (e.g., sad/tense/anxious vs. happy). We use daily FitBit data from 38 participants and ~1200 days of data to predict mood states (e.g., sad/tense/anxious vs. happy) on a day-to-day basis using an elastic net regression machine learning algorithm. We were able to accurately predict these states using a cross-validated machine learning algorithm and identified features predictive of each of the mood states. In this proof-of-concept analysis, we show that predicting daily mood states is feasible and may help to not only detect daily mood states but also improve passive awareness and deliver just-in-time interventions.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
No funding was received for this work.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
We used data from the LifeSnaps study sourced from Kaggle12. The details of this study are provided elsewhere, but we provide a brief overview here12. Participants were recruited from four sites and was approved by the Institutional Review Board (IRB) of the Aristotle University of Thessaloniki (Protocol Number 43661/2021).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.